Hyungkyung Kim

Dr. Hyungkyung Kim

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SBSeong-Eun Byun
Seong-Eun Byun
CSChanggon Sim
Changgon Sim
YJYunhui Jeong
Yunhui Jeong
HKHyungkyung Kim
Hyungkyung Kim
SPSungmoon Park
Sungmoon Park
Soonchul LeeSoonchul Lee
Soonchul Lee
Profound skeletal muscle loss can lead to severe disability and cosmetic deformities. Mesenchymal stem cell (MSC)-derived exosomes have shown potential as an effective therapeutic tool for tissue regeneration. This study aimed to determine the regenerative capacity of MSC-derived exosomes for skeletal muscle regeneration. Exosomes were isolated from human adipose tissue-derived MSCs (AD-MSCs). The effects of MSC-derived exosomes on satellite cells were investigated using cell viability, relevant genes, and protein analyses. Moreover, NOD-SCID mice were used and randomly assigned to the healthy control (n = 4), muscle defect (n = 6), and muscle defect + exosome (n = 6) groups. Muscle defects were created using a biopsy punch on the quadriceps of the hind limb. Four weeks after the surgery, the quadriceps muscles were harvested, weighed, and histologically analyzed. MSC-derived exosome treatment increased the proliferation and expression of myocyte-related genes, and immunofluorescence analysis for myogenin revealed a similar trend. Histologically, MSC-derived exosome-treated mice showed relatively preserved shapes and sizes of the muscle bundles. Immunohistochemical staining revealed greater expression of myogenin and myoblast determination protein 1 in the MSC-derived exosome-treated group. These results indicate that exosomes extracted from AD-MSCs have the therapeutic potential for skeletal muscle regeneration.

5 March 2024 in Cancers
Verified
Journal Article
Open access
PDF file
HKHyungkyung Kim
Hyungkyung Kim
EHEunkyung Han
Eunkyung Han
JLJeonghyo Lee
Jeonghyo Lee
Kwangil YimKwangil Yim
Kwangil Yim
JAJamshid Abdul-Ghafar
Jamshid Abdul-Ghafar
Yosep ChongYosep Chong
Yosep Chong
Ascites cytology is a cost-effective test for metastatic colorectal cancer (CRC) in the abdominal cavity. However, metastatic carcinoma of the peritoneum is difficult to diagnose based on biopsy findings, and ascitic aspiration cytology has a low sensitivity and specificity and a high inter-observer variability. The aim of the present study was to apply artificial intelligence (AI) to classify benign and malignant cells in ascites cytology patch images of metastatic CRC using a deep convolutional neural network. Datasets were collected from The OPEN AI Dataset Project, a nationwide cytology dataset for AI research. The numbers of patch images used for training, validation, and testing were 56,560, 7068, and 6534, respectively. We evaluated 1041 patch images of benign and metastatic CRC in the ascitic fluid to compare the performance of pathologists and an AI algorithm, and to examine whether the diagnostic accuracy of pathologists improved with the assistance of AI. This AI method showed an accuracy, a sensitivity, and a specificity of 93.74%, 87.76%, and 99.75%, respectively, for the differential diagnosis of malignant and benign ascites. The diagnostic accuracy and sensitivity of the pathologist with the assistance of the proposed AI method increased from 86.8% to 90.5% and from 73.3% to 79.3%, respectively. The proposed deep learning method may assist pathologists with different levels of experience in diagnosing metastatic CRC cells of ascites.

5 November 2025 in Medical Image Analysis
Verified
Journal Article
Closed access
SMSantanu Misra
Santanu Misra
SNSei Na
Sei Na
KPKyoungsook Park
Kyoungsook Park
CYChiho Yoon
Chiho Yoon
SMSampa Misra
Sampa Misra
Byullee ParkByullee Park
Byullee Park

1 January 2018 in Journal of the Korean Association of Oral and Maxillofacial Surgeons
Verified
Journal Article
Open access
PDF file
SKSe-Won Kim
Se-Won Kim
YJYu-Jin Jee
Yu-Jin Jee
DLDeok-Won Lee
Deok-Won Lee
HKHyungkyung Kim
Hyungkyung Kim
Kim SW, et al. J Korean Assoc Oral Maxillofac Surg. 2018 Oct;44(5):242-247. https://doi.org/10.5125/jkaoms.2018.44.5.242

30 August 2021 in Cells
Verified
Journal Article
Open access
PDF file
HAHyun-Ju An
Hyun-Ju An
KKKyung Rae Ko
Kyung Rae Ko
MBMinjung Baek
Minjung Baek
YJYunhui Jeong
Yunhui Jeong
HLHyeon Hae Lee
Hyeon Hae Lee
Soonchul LeeSoonchul Lee
Soonchul Lee
An important objective of vascularized tissue regeneration is to develop agents for osteonecrosis. We aimed to identify the pro-angiogenic and osteogenic efficacy of adipose tissue-derived (AD) pericytes combined with Nel-like protein-1 (NELL-1) to investigate the therapeutic effects on osteonecrosis. Tube formation and cell migration were assessed to determine the pro-angiogenic efficacy. Vessel formation was evaluated in vivo using the chorioallantoic membrane assay. A mouse model with a 2.5 mm necrotic bone fragment in the femoral shaft was used as a substitute for osteonecrosis in humans. Bone formation was assessed radiographically (plain radiographs, three-dimensional images, and quantitative analyses), and histomorphometric analyses were performed. To identify factors related to the effects of NELL-1, analysis using microarrays, qRT-PCR, and Western blotting was performed. The results for pro-angiogenic efficacy evaluation identified synergistic effects of pericytes and NELL-1 on tube formation, cell migration, and vessel formation. For osteogenic efficacy analysis, the mouse model for osteonecrosis was treated in combination with pericytes and NELL-1, and the results showed maximum bone formation using radiographic images and quantitative analyses, compared with other treatment groups and showed robust bone and vessel formation using histomorphometric analysis. We identified an association between FGF2 and the effects of NELL-1 using array-based analysis. Thus, combinatorial therapy using AD pericytes and NELL-1 may have potential as a novel treatment for osteonecrosis.

22 February 2024 in Gut and Liver
Verified
Journal Article
Open access
PDF file
YJYu Kyung Jun
Yu Kyung Jun
NKNayoung Kim
Nayoung Kim
HYHyuk Yoon
Hyuk Yoon
JPJi Hyun Park
Ji Hyun Park
HKHyungkyung Kim
Hyungkyung Kim
DLDong Ho Lee
Dong Ho Lee
Yu Kyung Jun, Nayoung Kim, Hyuk Yoon, Ji Hyun Park, Hyung Kyung Kim, Yonghoon Choi, Ji Ae Lee, Cheol Min Shin, Young Soo Park, Dong Ho Lee. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl230283